Sorry, this entry is only available in Ukrainian and Russian.
"Безвіз для ліків" та Україна як потужний фармацевтичний хаб: утопія чи реальність
Вас может заинтересовать:
WEB only
The life science group Sartorius and Repligen Corporation today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified…
WEB only
Pharmaceutical Company ‘Darnytsia’ has registered in Poland a medicinal product used in the complex treatment of acute and chronic heart failure, acute and chronic renal failure, nephrotic syndrome, liver diseases,…
